Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA Margin 2010-2025 | GILD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Gilead Sciences (GILD) over the last 10 years. The current EBITDA margin for Gilead Sciences as of March 31, 2025 is .
  
Gilead Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $28.74B $10.99B 38.26%
2024-12-31 $28.75B $4.43B 15.40%
2024-09-30 $28.30B $3.59B 12.67%
2024-06-30 $27.81B $5.31B 19.11%
2024-03-31 $27.45B $4.32B 15.74%
2023-12-31 $27.12B $10.30B 37.98%
2023-09-30 $27.39B $10.79B 39.40%
2023-06-30 $27.38B $10.85B 39.61%
2023-03-31 $27.04B $11.06B 40.88%
2022-12-31 $27.28B $9.43B 34.58%
2022-09-30 $27.14B $8.11B 29.90%
2022-06-30 $27.52B $9.12B 33.13%
2022-03-31 $27.47B $9.33B 33.95%
2021-12-31 $27.31B $11.97B 43.83%
2021-09-30 $27.48B $13.57B 49.38%
2021-06-30 $26.64B $11.56B 43.40%
2021-03-31 $25.56B $6.16B 24.11%
2020-12-31 $24.69B $5.55B 22.48%
2020-09-30 $23.15B $3.92B 16.92%
2020-06-30 $22.17B $0.43B 1.96%
2020-03-31 $22.72B $5.85B 25.74%
2019-12-31 $22.45B $5.69B 25.35%
2019-09-30 $22.37B $5.75B 25.71%
2019-06-30 $22.36B $9.86B 44.09%
2019-03-31 $22.32B $9.72B 43.53%
2018-12-31 $22.13B $9.63B 43.52%
2018-09-30 $22.28B $10.82B 48.54%
2018-06-30 $23.20B $11.94B 51.49%
2018-03-31 $24.69B $13.86B 56.13%
2017-12-31 $26.11B $15.41B 59.03%
2017-09-30 $27.48B $17.06B 62.08%
2017-06-30 $28.47B $17.65B 62.00%
2017-03-31 $29.10B $17.92B 61.57%
2016-12-31 $30.39B $18.79B 61.83%
2016-09-30 $31.58B $20.35B 64.46%
2016-06-30 $32.37B $21.52B 66.47%
2016-03-31 $32.84B $22.59B 68.77%
2015-12-31 $32.64B $23.29B 71.36%
2015-09-30 $31.45B $22.00B 69.95%
2015-06-30 $29.19B $19.88B 68.10%
2015-03-31 $27.49B $18.67B 67.93%
2014-12-31 $24.89B $16.32B 65.55%
2014-09-30 $20.70B $13.04B 62.98%
2014-06-30 $17.44B $10.50B 60.24%
2014-03-31 $13.67B $7.05B 51.60%
2013-12-31 $11.20B $4.87B 43.47%
2013-09-30 $10.67B $4.72B 44.27%
2013-06-30 $10.31B $4.62B 44.81%
2013-03-31 $9.95B $4.52B 45.44%
2012-12-31 $9.70B $4.29B 44.20%
2012-09-30 $9.31B $4.05B 43.47%
2012-06-30 $9.01B $4.01B 44.52%
2012-03-31 $8.74B $3.98B 45.49%
2011-12-31 $8.39B $4.09B 48.81%
2011-09-30 $8.18B $4.06B 49.60%
2011-06-30 $8.00B $4.03B 50.38%
2011-03-31 $7.79B $3.99B 51.21%
2010-12-31 $7.95B $4.23B 53.17%
2010-09-30 $7.98B $4.45B 55.74%
2010-06-30 $7.85B $4.35B 55.48%
2010-03-31 $7.57B $4.12B 54.40%
2009-12-31 $7.01B $3.74B 53.38%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $139.009B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $215.386B 16.08
Amgen (AMGN) United States $160.365B 14.37
Vertex Pharmaceuticals (VRTX) United States $118.029B 0.00
Bristol Myers Squibb (BMY) United States $95.486B 6.39
GSK (GSK) United Kingdom $78.168B 9.36
CSL (CSLLY) Australia $77.435B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.096B 14.34
Alnylam Pharmaceuticals (ALNY) United States $43.277B 0.00
Argenex SE (ARGX) Netherlands $33.185B 90.58
BioNTech SE (BNTX) Germany $26.443B 0.00
Royalty Pharma (RPRX) United States $20.449B 8.64
Biogen (BIIB) United States $19.469B 8.40
Insmed (INSM) United States $18.554B 0.00
Illumina (ILMN) United States $15.957B 30.27
Incyte (INCY) United States $13.250B 100.66
Genmab (GNMSF) Denmark $13.116B 13.41
Genmab (GMAB) Denmark $13.017B 14.60
Exelixis (EXEL) United States $12.585B 21.37
Moderna (MRNA) United States $11.792B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $11.368B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.027B 17.91
QIAGEN (QGEN) Netherlands $10.746B 20.91
Ascendis Pharma (ASND) Denmark $10.648B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.066B 0.00
Bio-Techne Corp (TECH) United States $8.331B 31.08
Blueprint Medicines (BPMC) United States $8.289B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.792B 0.00
Roivant Sciences (ROIV) United Kingdom $7.471B 0.00
Repligen (RGEN) United States $7.162B 80.17
Revolution Medicines (RVMD) United States $7.054B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.654B 12.74
Jazz Pharmaceuticals (JAZZ) Ireland $6.623B 6.50
Legend Biotech (LEGN) United States $6.549B 0.00
Guardant Health (GH) United States $6.256B 0.00
TG Therapeutics (TGTX) United States $5.829B 153.00
Nuvalent (NUVL) United States $5.779B 0.00
Telix Pharmaceuticals (TLX) Australia $5.438B 0.00
Anbio Biotechnology (NNNN) Germany $5.323B 0.00
Axsome Therapeutics (AXSM) United States $5.191B 0.00
Alkermes (ALKS) Ireland $4.757B 12.77
CRISPR Therapeutics AG (CRSP) Switzerland $4.506B 0.00
ADMA Biologics Inc (ADMA) United States $4.364B 32.64
Vaxcyte (PCVX) United States $4.289B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.184B 0.00
Cytokinetics (CYTK) United States $4.139B 0.00
Krystal Biotech (KRYS) United States $4.135B 31.87
Akero Therapeutics (AKRO) United States $4.127B 0.00
Zealand Pharma (ZLDPF) Denmark $4.102B 0.00
Zai Lab (ZLAB) China $4.043B 0.00
PTC Therapeutics (PTCT) United States $3.889B 6.77
Ultragenyx Pharmaceutical (RARE) United States $3.773B 0.00
Ascentage Pharma Group - (AAPG) China $3.733B 0.00
Merus (MRUS) Netherlands $3.725B 0.00
Arcellx (ACLX) United States $3.701B 0.00
Avidity Biosciences (RNA) United States $3.516B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.506B 30.81
Scholar Rock Holding (SRRK) United States $3.417B 0.00
Viking Therapeutics (VKTX) United States $3.166B 0.00
Protagonist Therapeutics (PTGX) United States $3.164B 68.07
MoonLake Immunotherapeutics (MLTX) Switzerland $3.130B 0.00
Metsera (MTSR) United States $3.094B 0.00
Kymera Therapeutics (KYMR) United States $2.917B 0.00
Immunovant (IMVT) United States $2.897B 0.00
Alvotech (ALVO) Luxembourg $2.771B 15.85
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.756B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.552B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.492B 0.00
ImmunityBio (IBRX) United States $2.401B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.319B 0.00
Apellis Pharmaceuticals (APLS) United States $2.295B 0.00
Twist Bioscience (TWST) United States $2.287B 0.00
Ligand Pharmaceuticals (LGND) United States $2.211B 0.00
Apogee Therapeutics (APGE) United States $2.185B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.142B 0.00
Denali Therapeutics (DNLI) United States $2.134B 0.00
Vericel (VCEL) United States $2.101B 1391.33
Bavarian Nordic (BVNRY) Denmark $2.091B 11.05
Agios Pharmaceuticals (AGIO) United States $2.089B 0.00
CG Oncology (CGON) United States $2.050B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.034B 0.00
Beam Therapeutics (BEAM) United States $2.012B 0.00
NovoCure (NVCR) Jersey $1.974B 0.00
IDEAYA Biosciences (IDYA) United States $1.936B 0.00
Disc Medicine (IRON) United States $1.896B 0.00
Belite Bio (BLTE) United States $1.893B 0.00
Amicus Therapeutics (FOLD) United States $1.878B 203.33
Harmony Biosciences Holdings (HRMY) United States $1.847B 12.27
Certara (CERT) United States $1.838B 34.33
Adaptive Biotechnologies (ADPT) United States $1.793B 0.00
Sarepta Therapeutics (SRPT) United States $1.793B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.729B 0.00
GRAIL (GRAL) United States $1.681B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.659B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.647B 0.00
Vera Therapeutics (VERA) United States $1.531B 0.00
Biohaven (BHVN) United States $1.494B 0.00
89BIO (ETNB) United States $1.483B 0.00
Celldex Therapeutics (CLDX) United States $1.460B 0.00
Janux Therapeutics (JANX) United States $1.447B 0.00
ANI Pharmaceuticals (ANIP) United States $1.414B 14.57
Edgewise Therapeutics (EWTX) United States $1.371B 0.00
Mesoblast (MESO) Australia $1.365B 0.00
Travere Therapeutics (TVTX) United States $1.333B 0.00
Viridian Therapeutics (VRDN) United States $1.279B 0.00
Dynavax Technologies (DVAX) United States $1.233B 73.36
CureVac (CVAC) Germany $1.223B 5.92
Structure Therapeutics (GPCR) United States $1.168B 0.00
AbCellera Biologics (ABCL) Canada $1.134B 0.00
Intellia Therapeutics (NTLA) United States $1.112B 0.00
Novavax (NVAX) United States $1.101B 2.57
MannKind (MNKD) United States $1.094B 22.50
WAVE Life Sciences (WVE) Singapore $1.081B 0.00
Pacira BioSciences (PCRX) United States $1.075B 10.23
Liquidia Technologies (LQDA) United States $1.042B 0.00
Niagen Bioscience (NAGE) United States $1.001B 141.22
Cidara Therapeutics (CDTX) United States $0.984B 0.00
BGM Group (BGM) China $0.975B 0.00
Pharvaris (PHVS) Netherlands $0.973B 0.00
NeoGenomics (NEO) United States $0.972B 0.00
Nurix Therapeutics (NRIX) United States $0.970B 0.00
Praxis Precision Medicines (PRAX) United States $0.963B 0.00
Spyre Therapeutics (SYRE) United States $0.950B 0.00
Mineralys Therapeutics (MLYS) United States $0.948B 0.00
MiMedx (MDXG) United States $0.936B 22.64
Sionna Therapeutics (SION) United States $0.935B 0.00
Anavex Life Sciences (AVXL) United States $0.921B 0.00
Oric Pharmaceuticals (ORIC) United States $0.920B 0.00
LENZ Therapeutics (LENZ) United States $0.916B 0.00
Geron (GERN) United States $0.911B 0.00
Zymeworks (ZYME) United States $0.909B 0.00
Arcus Biosciences (RCUS) United States $0.897B 0.00
Cogent Biosciences (COGT) United States $0.863B 0.00
Oculis Holding AG (OCS) Switzerland $0.830B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.790B 0.00
CorMedix Inc (CRMD) United States $0.788B 52.82
GH Research (GHRS) Ireland $0.776B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.769B 0.00
Gyre Therapeutics (GYRE) United States $0.762B 203.25
Vir Biotechnology (VIR) United States $0.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.745B 0.00
Replimune (REPL) United States $0.725B 0.00
Pharming Group (PHAR) Netherlands $0.720B 0.00
Sana Biotechnology (SANA) United States $0.719B 0.00
Nuvation Bio (NUVB) United States $0.711B 0.00
ArriVent BioPharma (AVBP) United States $0.711B 0.00
Trevi Therapeutics (TRVI) United States $0.698B 0.00
AnaptysBio (ANAB) United States $0.698B 0.00
Immatics (IMTX) Germany $0.694B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.689B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.669B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Stoke Therapeutics (STOK) United States $0.627B 14.53
Urogen Pharma (URGN) United States $0.626B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.623B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Tango Therapeutics (TNGX) United States $0.618B 0.00
Dianthus Therapeutics (DNTH) United States $0.606B 0.00
Jyong Biotech (MENS) Taiwan $0.604B 0.00
MeiraGTx Holdings (MGTX) United States $0.604B 0.00
Upstream Bio (UPB) United States $0.602B 0.00
Castle Biosciences (CSTL) United States $0.586B 39.80
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Arvinas (ARVN) United States $0.580B 0.00
Sage Therapeutics (SAGE) United States $0.576B 0.00
Keros Therapeutics (KROS) United States $0.546B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.542B 0.00
Tyra Biosciences (TYRA) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.522B 0.00
Myriad Genetics (MYGN) United States $0.516B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.515B 0.00
Kura Oncology (KURA) United States $0.507B 0.00
Septerna (SEPN) United States $0.507B 0.00
Abivax SA (ABVX) France $0.505B 0.00
Maze Therapeutics (MAZE) United States $0.504B 0.00
Bicara Therapeutics (BCAX) United States $0.492B 0.00
Precigen (PGEN) United States $0.478B 0.00
Cytek Biosciences (CTKB) United States $0.476B 0.00
ATyr Pharma (ATYR) United States $0.473B 0.00
Fortrea Holdings (FTRE) United States $0.472B 13.05
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.456B 0.00
Kamada (KMDA) Israel $0.453B 27.17
Oxford BioMedica (OXBDF) United Kingdom $0.448B 0.00
Rapport Therapeutics (RAPP) United States $0.439B 0.00
REGENXBIO (RGNX) United States $0.438B 0.00
PureTech Health (PRTC) United States $0.433B 0.00
Zenas BioPharma (ZBIO) United States $0.420B 0.00
Prime Medicine (PRME) United States $0.418B 0.00
MBX Biosciences (MBX) United States $0.417B 0.00
Rezolute (RZLT) United States $0.412B 0.00
Erasca (ERAS) United States $0.408B 0.00
Tectonic Therapeutic (TECX) United States $0.398B 0.00
Solid Biosciences (SLDB) United States $0.390B 0.00
ITeos Therapeutics (ITOS) United States $0.390B 0.00
Eton Pharmaceuticals (ETON) United States $0.388B 0.00
Compass Therapeutics (CMPX) United States $0.384B 0.00
Vigil Neuroscience (VIGL) United States $0.381B 0.00
Emergent Biosolutions (EBS) United States $0.379B 0.00
Citius Oncology (CTOR) United States $0.379B 0.00
Terns Pharmaceuticals (TERN) United States $0.377B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Fulcrum Therapeutics (FULC) United States $0.374B 0.00
Northwest Biotherapeutics (NWBO) United States $0.362B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Absci (ABSI) United States $0.353B 0.00
Amarin (AMRN) Ireland $0.346B 0.00
Prothena (PRTA) Ireland $0.346B 0.00
Benitec Biopharma (BNTC) United States $0.346B 0.00
Aura Biosciences (AURA) United States $0.330B 0.00
Astria Therapeutics (ATXS) United States $0.328B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.326B 0.00
XOMA Royalty (XOMA) United States $0.323B 0.00
Atea Pharmaceuticals (AVIR) United States $0.320B 0.00
DBV Technologies S.A (DBVT) France $0.318B 0.00
Annexon (ANNX) United States $0.317B 0.00
Olema Pharmaceuticals (OLMA) United States $0.313B 0.00
Crescent Biopharma (CBIO) United States $0.311B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.310B 0.00
Aardvark Therapeutics (AARD) United States $0.302B 0.00
Abeona Therapeutics (ABEO) United States $0.301B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.300B 60.88
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
Cartesian Therapeutics (RNAC) United States $0.291B 0.00
Inventiva S.A (IVA) France $0.288B 0.00
Neurogene (NGNE) United States $0.287B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.285B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Gossamer Bio (GOSS) United States $0.282B 0.00
Ocugen (OCGN) United States $0.279B 0.00
Alpha Teknova (TKNO) United States $0.278B 0.00
Entrada Therapeutics (TRDA) United States $0.274B 8.93
Corvus Pharmaceuticals (CRVS) United States $0.269B 0.00
Palvella Therapeutics (PVLA) United States $0.267B 0.00
Verastem (VSTM) United States $0.264B 0.00
Allogene Therapeutics (ALLO) United States $0.260B 0.00
Candel Therapeutics (CADL) United States $0.256B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.251B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Cardiff Oncology (CRDF) United States $0.243B 0.00
Adherex Technologies (FENC) United States $0.243B 0.00
Vor Biopharma (VOR) $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
Inhibrx Biosciences (INBX) United States $0.236B 0.14
Codexis (CDXS) United States $0.229B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Monopar Therapeutics (MNPR) United States $0.222B 0.00
SELLAS Life Sciences (SLS) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Editas Medicine (EDIT) United States $0.215B 0.00
Design Therapeutics (DSGN) United States $0.214B 0.00
Tvardi Therapeutics (TVRD) United States $0.210B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Kodiak Sciences (KOD) United States $0.208B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
CARGO Therapeutics (CRGX) United States $0.206B 0.00
CytomX Therapeutics (CTMX) United States $0.202B 5.21
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
BioStem Technologies (BSEM) $0.200B 8.12
Y-mAbs Therapeutics (YMAB) United States $0.195B 0.00
EnGene Holdings (ENGN) Canada $0.194B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
Alumis (ALMS) United States $0.185B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.184B 0.00
Instil Bio (TIL) United States $0.180B 0.00
Puma Biotechnology (PBYI) United States $0.178B 4.65
Voyager Therapeutics (VYGR) United States $0.177B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.176B 0.00
I-Mab (IMAB) United States $0.176B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Alpha Cognition (ACOG) Canada $0.168B 0.00
Agenus (AGEN) United States $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
DiaMedica Therapeutics (DMAC) United States $0.161B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Compugen (CGEN) Israel $0.157B 0.00
BioAge Labs (BIOA) United States $0.153B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Alector (ALEC) United States $0.151B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Theratechnologies (THTX) Canada $0.147B 0.00
Black Diamond Therapeutics (BDTX) United States $0.147B 43.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.145B 0.00
Skye Bioscience (SKYE) United States $0.143B 0.00
23andMe Holding (MEHCQ) United States $0.135B 0.00
Greenwich LifeSciences (GLSI) United States $0.134B 0.00
Seer (SEER) United States $0.134B 0.00
Rapt Therapeutics (RAPT) United States $0.133B 0.00
Neumora Therapeutics (NMRA) United States $0.133B 0.00
Actuate Therapeutics (ACTU) United States $0.129B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Caribou Biosciences (CRBU) United States $0.127B 0.00
Elicio Therapeutics (ELTX) United States $0.127B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Immuneering (IMRX) United States $0.124B 0.00
Sangamo Therapeutics (SGMO) United States $0.123B 0.00
Kyverna Therapeutics (KYTX) United States $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
Genelux (GNLX) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.111B 0.00
TuHURA Biosciences (HURA) United States $0.108B 0.00
C4 Therapeutics (CCCC) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Seres Therapeutics (MCRB) United States $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.103B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Jasper Therapeutics (JSPR) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.100B 0.00
Tenaya Therapeutics (TNYA) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
XBiotech (XBIT) United States $0.097B 0.00
OKYO Pharma (OKYO) $0.094B 0.00
Coherus Oncology (CHRS) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.091B 0.00
Forte Biosciences (FBRX) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.090B 0.00
Invivyd (IVVD) United States $0.088B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Adagene (ADAG) China $0.087B 0.00
Oncolytics Biotech (ONCY) Canada $0.087B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
Elutia (ELUT) United States $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
TScan Therapeutics (TCRX) United States $0.085B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Cabaletta Bio (CABA) United States $0.083B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
TELA Bio (TELA) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Immix Biopharma (IMMX) United States $0.071B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.070B 0.00
Immunic (IMUX) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.069B 0.00
Akoya Biosciences (AKYA) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.066B 0.00
Connect Biopharma Holdings (CNTB) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Alto Neuroscience (ANRO) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
MediciNova (MNOV) United States $0.061B 0.00
PDS Biotechnology (PDSB) United States $0.061B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
INmune Bio (INMB) United States $0.060B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Senti Biosciences (SNTI) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
ABVC BioPharma (ABVC) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Quantum Biopharma (QNTM) Canada $0.050B 0.00
CervoMed (CRVO) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Medicus Pharma (MDCX) United States $0.046B 0.00
Applied Therapeutics (APLT) United States $0.045B 0.00
Pluri (PLUR) Israel $0.045B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
Exicure (XCUR) United States $0.043B 0.00
PepGen (PEPG) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.040B 0.00
Artiva Biotherapeutics (ARTV) United States $0.039B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
Radiopharm Theranostics - (RADX) Australia $0.031B 0.00
Rani Therapeutics Holdings (RANI) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Passage Bio (PASG) United States $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Cognition Therapeutics (CGTX) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
Generation Bio (GBIO) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
NextCure (NXTC) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Equillium (EQ) United States $0.011B 0.00
Abpro Holdings (ABP) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GeoVax Labs (GOVX) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
UNITY Biotechnology (UBX) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00